探索血清α-synuclein及其本质震中的自身抗体:对诊断和症状相关性的影响
Ali Shalash1, Ahmed Doma1, Mai Barakat2
1Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo 11757, Egypt.
Biomedical reports
|June 13, 2024
概括
血清α-synuclein (α-syn) 水平在与对照组相比,在基本震 (ET) 患者中较低. 这一发现表明α-syn可能作为诊断ET的潜在生物标志物.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 基本震 (ET) 缺乏明确的诊断生物标志物,使得与帕金森病等其他神经系统疾病的区分变得复杂.
- 研究血清生物标志物对于改善ET诊断和管理至关重要.
研究的目的:
- 为了比较ET患者与健康对照者的血清α-synuclein (α-syn) 蛋白和自身抗体水平.
- 探索血清α-syn水平和ET患者的临床症状之间的关系.
主要方法:
- 来自32名ET患者和32名匹配对照者的血清样本被分析为α-syn和anti-α-syn自身抗体.
- 标准化尺度评估了非运动症状,认知功能,抑郁,焦虑和生活质量.
- 震的严重程度使用法恩-托洛萨-马林震评级尺度进行评估.
主要成果:
- 血清α-syn度在ET患者中明显低于对照组 (P<0.001),预测值为0.81 (阳性) 和0.75 (阴性).
- 两组之间血清抗α-syn自身抗体水平没有发现显著差异.
- 血清α-syn或自身抗体水平与ET患者的临床特征之间没有观察到相关性.
结论:
- 在ET患者的血清α-syn水平较低,具有有利的预测值,表明其作为诊断生物标志物的潜力.
- ET患者在认知功能,情绪和生活质量方面表现出显著的缺陷,独立于血清α-syn水平.
相关概念视频
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524


